Spots Global Cancer Trial Database for epoetin beta
Every month we try and update this database with for epoetin beta cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies | NCT00776425 | Anemia | Epoetin beta | 18 Years - | Hoffmann-La Roche | |
| Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients | NCT00628043 | Anemia | epoetin beta placebo | 20 Years - 79 Years | Chugai Pharmaceutical | |
| A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B | NCT02608060 | Anemia | Epoetin Beta | 18 Years - | Hoffmann-La Roche | |
| A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies | NCT02564094 | Anemia | Epoetin beta | 18 Years - | Hoffmann-La Roche | |
| A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy | NCT02624141 | Anemia | Epoetin Beta | 18 Years - | Hoffmann-La Roche | |
| Epoetin Beta in Treating Anemia in Patients With Cervical Cancer | NCT00046969 | Anemia Cervical Cancer | epoetin beta cisplatin brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors | NCT00559195 | Anemia Fatigue Unspecified Adu... | epoetin beta quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors | NCT02554942 | Anemia | Epoetin beta | 18 Years - | Hoffmann-La Roche | |
| Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality. | NCT01718379 | Myelodysplastic... | Lenalidomide Epoetin beta | 18 Years - | Groupe Francophone des Myelodysplasies | |
| A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy | NCT02761642 | Anemia | Epoetin Beta | 18 Years - | Hoffmann-La Roche | |
| Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors | NCT00875004 | Anemia Unspecified Adu... | epoetin beta systemic chemot... quality-of-life... | 18 Years - 120 Years | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Epoetin Beta in Treating Anemia in Patients With Cervical Cancer | NCT00046969 | Anemia Cervical Cancer | epoetin beta cisplatin brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors | NCT00559195 | Anemia Fatigue Unspecified Adu... | epoetin beta quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS) | NCT02145026 | Myelodysplastic... | Epoetin beta | 18 Years - | Hoffmann-La Roche | |
| Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA) | NCT01015352 | Myelodysplastic... | Azacitidine Epoetin beta | 18 Years - | Groupe Francophone des Myelodysplasies | |
| Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients | NCT00628043 | Anemia | epoetin beta placebo | 20 Years - 79 Years | Chugai Pharmaceutical | |
| A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy | NCT02761642 | Anemia | Epoetin Beta | 18 Years - | Hoffmann-La Roche | |
| A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies | NCT00776425 | Anemia | Epoetin beta | 18 Years - | Hoffmann-La Roche | |
| A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS) | NCT02145026 | Myelodysplastic... | Epoetin beta | 18 Years - | Hoffmann-La Roche |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
